Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOLFIRI vs Observation in Resected Stage II Colon Cancer
NCT00091312Phase 3Unknown
- Sponsor
- Fédération Francophone de Cancérologie Digestive
- Start
- Jun 2004
- Modality
- Orthosteric Ligands
- Countries
- 6
01
Overview
Phase 3, randomised, open-label trial of irinotecan, fluorouracil and folinic acid in colon cancer (2 arms), sponsored by Fédération Francophone de Cancérologie Digestive. Primary endpoint: Disease-Free Survival at 5 years. Status: unknown.
02
Drugs
irinotecanfluorouracilfolinic acid
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT00091312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00091312.